CT radiomics-based machine learning classification of atypical cartilaginous tumours and appendicular chondrosarcomas.


Journal

EBioMedicine
ISSN: 2352-3964
Titre abrégé: EBioMedicine
Pays: Netherlands
ID NLM: 101647039

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 20 02 2021
revised: 05 05 2021
accepted: 05 05 2021
pubmed: 30 5 2021
medline: 15 12 2021
entrez: 29 5 2021
Statut: ppublish

Résumé

Clinical management ranges from surveillance or curettage to wide resection for atypical to higher-grade cartilaginous tumours, respectively. Our aim was to investigate the performance of computed tomography (CT) radiomics-based machine learning for classification of atypical cartilaginous tumours and higher-grade chondrosarcomas of long bones. One-hundred-twenty patients with histology-proven lesions were retrospectively included. The training cohort consisted of 84 CT scans from centre 1 (n=55 G1 or atypical cartilaginous tumours; n=29 G2-G4 chondrosarcomas). The external test cohort consisted of the CT component of 36 positron emission tomography-CT scans from centre 2 (n=16 G1 or atypical cartilaginous tumours; n=20 G2-G4 chondrosarcomas). Bidimensional segmentation was performed on preoperative CT. Radiomic features were extracted. After dimensionality reduction and class balancing in centre 1, the performance of a machine-learning classifier (LogitBoost) was assessed on the training cohort using 10-fold cross-validation and on the external test cohort. In centre 2, its performance was compared with preoperative biopsy and an experienced radiologist using McNemar's test. The classifier had 81% (AUC=0.89) and 75% (AUC=0.78) accuracy in identifying the lesions in the training and external test cohorts, respectively. Specifically, its accuracy in classifying atypical cartilaginous tumours and higher-grade chondrosarcomas was 84% and 78% in the training cohort, and 81% and 70% in the external test cohort, respectively. Preoperative biopsy had 64% (AUC=0.66) accuracy (p=0.29). The radiologist had 81% accuracy (p=0.75). Machine learning showed good accuracy in classifying atypical and higher-grade cartilaginous tumours of long bones based on preoperative CT radiomic features. ESSR Young Researchers Grant.

Sections du résumé

BACKGROUND BACKGROUND
Clinical management ranges from surveillance or curettage to wide resection for atypical to higher-grade cartilaginous tumours, respectively. Our aim was to investigate the performance of computed tomography (CT) radiomics-based machine learning for classification of atypical cartilaginous tumours and higher-grade chondrosarcomas of long bones.
METHODS METHODS
One-hundred-twenty patients with histology-proven lesions were retrospectively included. The training cohort consisted of 84 CT scans from centre 1 (n=55 G1 or atypical cartilaginous tumours; n=29 G2-G4 chondrosarcomas). The external test cohort consisted of the CT component of 36 positron emission tomography-CT scans from centre 2 (n=16 G1 or atypical cartilaginous tumours; n=20 G2-G4 chondrosarcomas). Bidimensional segmentation was performed on preoperative CT. Radiomic features were extracted. After dimensionality reduction and class balancing in centre 1, the performance of a machine-learning classifier (LogitBoost) was assessed on the training cohort using 10-fold cross-validation and on the external test cohort. In centre 2, its performance was compared with preoperative biopsy and an experienced radiologist using McNemar's test.
FINDINGS RESULTS
The classifier had 81% (AUC=0.89) and 75% (AUC=0.78) accuracy in identifying the lesions in the training and external test cohorts, respectively. Specifically, its accuracy in classifying atypical cartilaginous tumours and higher-grade chondrosarcomas was 84% and 78% in the training cohort, and 81% and 70% in the external test cohort, respectively. Preoperative biopsy had 64% (AUC=0.66) accuracy (p=0.29). The radiologist had 81% accuracy (p=0.75).
INTERPRETATION CONCLUSIONS
Machine learning showed good accuracy in classifying atypical and higher-grade cartilaginous tumours of long bones based on preoperative CT radiomic features.
FUNDING BACKGROUND
ESSR Young Researchers Grant.

Identifiants

pubmed: 34051442
pii: S2352-3964(21)00200-0
doi: 10.1016/j.ebiom.2021.103407
pmc: PMC8170113
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

103407

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no potential conflict of interest related to this work.

Auteurs

Salvatore Gitto (S)

Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy. Electronic address: sal.gitto@gmail.com.

Renato Cuocolo (R)

Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli "Federico II", Naples, Italy; Laboratory of Augmented Reality for Health Monitoring (ARHeMLab), Dipartimento di Ingegneria Elettrica e delle Tecnologie dell'Informazione, Università degli Studi di Napoli "Federico II", Naples, Italy.

Alessio Annovazzi (A)

Nuclear Medicine Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Vincenzo Anelli (V)

Radiology and Diagnostic Imaging Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Marzia Acquasanta (M)

IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.

Antonino Cincotta (A)

Scuola di Specializzazione in Radiodiagnostica, Università degli Studi di Milano, Milan, Italy.

Domenico Albano (D)

IRCCS Istituto Ortopedico Galeazzi, Milan, Italy; Sezione di Scienze Radiologiche, Dipartimento di Biomedicina, Neuroscienze e Diagnostica Avanzata, Università degli Studi di Palermo, Palermo, Italy.

Vito Chianca (V)

Ospedale Evangelico Betania, Naples, Italy; Clinica di Radiologia, Istituto Imaging della Svizzera Italiana - Ente Ospedaliero Cantonale, Lugano, Switzerland.

Virginia Ferraresi (V)

First Medical Oncology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Carmelo Messina (C)

IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.

Carmine Zoccali (C)

Oncological Orthopaedics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Elisabetta Armiraglio (E)

Pathology Department, ASST Pini - CTO, Milan, Italy.

Antonina Parafioriti (A)

Pathology Department, ASST Pini - CTO, Milan, Italy.

Rosa Sciuto (R)

Nuclear Medicine Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Alessandro Luzzati (A)

IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.

Roberto Biagini (R)

Oncological Orthopaedics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Massimo Imbriaco (M)

Dipartimento di Scienze Biomediche Avanzate, Università degli Studi di Napoli "Federico II", Naples, Italy.

Luca Maria Sconfienza (LM)

Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy; IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH